Randomized controlled trial of TDCS on cognition in 201 seniors with mild neurocognitive disorder
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Objective: To examine the efficacy and safety of combined transcranial direct current stimulation (tDCS) and working memory training (WMT) in enhancing the cognitive functions for individuals with mild neurocognitive disorder due to AD (NCD‐AD). Methods: In this double‐blind, sham‐controlled randomized clinical trial (RCT), 201 patients with NCD‐AD were randomly assigned for a 4‐week intervention of either a combination of tDCS and WMT, sham tDCS and WMT, or tDCS and control cognitive training (CCT). Global cognition and domain‐specific cognitive function were assessed before and after the intervention with Alzheimer's disease assessment scale‐cognitive subscale (ADAS‐Cog), category verbal fluency test, logical memory, digit, and visual span tests. Results: Study participants did not show intervention group differences in baseline demographics, or cognitive characteristics (ANOVA). Cognitive enhancement was found across three groups after 4 weeks intervention. Combined tDCS‐WMT group showed significantly greater improvement compared with single‐modality groups in delayed recall (P = 0.043, η2 = 0.036) and working memory capacity (P = 0.04, η2 = 0.038) at 4th week, and logical memory at 12th week (P = 0.042, η2 = 0.037). Adverse events, including skin lesions (2.2%), were similar between groups. Interpretation: tDCS or WMT could be a safe, feasible, and effective intervention for individuals with NCD‐AD. A combination of tDCS and WMT presents greater cognitive enhancement, which may highlight the potential synergistic effects of combined modality intervention on cognition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nichols, E., Szoeke, C. E. I., Vollset, S. E., Abbasi, N., Abd-Allah, F., Abdela, J., Aichour, M. T. E., Akinyemi, R. O., Alahdab, F., Asgedom, S. W., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30403-4 · Cited by 2,412 · cited 1×
“With rapid population aging in China and globally, Alzheimer’s disease (AD) is expected to have profound impacts on individuals and society.(1,2) At present, there are no effective pharmacological treatments to halt or slow down cognitive decline in AD.”
BackgroundEffects of Cognitive Training Interventions With Older Adults: A Randomized Controlled Trial
Ball, K., Berch, D. B., Helmers, K. F., Jobe, J. B., Leveck, M. D., Marsiske, M., Morris, J. N., Rebok, G. W., Smith, D. M., Tennstedt, S. L., et al. (2002) · JAMA · doi:10.1001/jama.288.18.2271 · Cited by 2,049
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Salloway, S., Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1304839 · Cited by 1,960
Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease
Honig, L. S., Vellas, B., Woodward, M., Boada, M., Bullock, R., Borrie, M., Hager, K., Andreasen, N., Scarpini, E., Liu-Seifert, H., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1705971 · Cited by 1,049
Short- and long-term benefits of cognitive training
Jaeggi, S. M., Buschkuehl, M., Jonides, J., & Shah, P. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103228108 · Cited by 769
The cost of Alzheimer's disease in China and re‐estimation of costs worldwide
Jia, J., Wei, C., Chen, S., Li, F., Tang, Y., Qin, W., Zhao, L., Jin, H., Xu, H., Wang, F., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.12.006 · Cited by 752 · cited 1×
“With rapid population aging in China and globally, Alzheimer’s disease (AD) is expected to have profound impacts on individuals and society.(1,2) At present, there are no effective pharmacological treatments to halt or slow down cognitive decline in AD.”
BackgroundRandomized trial of verubecestat for mild-to-moderate Alzheimer's disease
Egan, M. F., Kost, J., Tariot, P. N., Aisen, P. S., Cummings, J. L., Vellas, B., Sur, C., Mukai, Y., Voss, T., Furtek, C., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1706441 · Cited by 685
Working memory plasticity in old age: practice gain, transfer, and maintenance
Li, S.-C., Schmiedek, F., Huxhold, O., Röcke, C., Smith, J., & Lindenberger, U. (2008) · Psychology and Aging · doi:10.1037/a0014343 · Cited by 369 · cited 1×
“, working memory)(6,7) or across the other cognitive functions.(8,9) A noninvasive brain stimulation (NIBS), transcranial direct current stimulation (tDCS), also presents a promising efficacy.”
BackgroundClosed-loop stimulation of temporal cortex rescues functional networks and improves memory
Ezzyat, Y., Wanda, P. A., Levy, D. F., Kadel, A., Aka, A., Pedisich, I., Sperling, M. R., Sharan, A. D., Lega, B. C., Burks, A., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02753-0 · Cited by 347
Working memory training in older adults: Evidence of transfer and maintenance effects.
Borella, E., Carretti, B., Riboldi, F., & De Beni, R. (2010) · Psychology and Aging · doi:10.1037/a0020683 · Cited by 328 · cited 1×
“, working memory)(6,7) or across the other cognitive functions.(8,9) A noninvasive brain stimulation (NIBS), transcranial direct current stimulation (tDCS), also presents a promising efficacy.”
Background
Cited by
Talar, K., Vetrovsky, T., van Haren, M., Négyesi, J., Granacher, U., Váczi, M., Martín-Arévalo, E., Del Olmo, M. F., Kałamacka, E., & Hortobágyi, T. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101738 · Cited by 59
Yang, T., Liu, W., He, J., Gui, C., Meng, L., Xu, L., & Jia, C. (2024) · Alzheimer's Research & Therapy · doi:10.1186/s13195-024-01505-9 · Cited by 59
Neurodegenerative Disorders of Speech and Language: Non-language-dominant Diseases
García, A. M., DeLeon, J., & Tee, B. L. (2022) · Encyclopedia of Behavioral Neuroscience, 2nd edition · doi:10.1016/b978-0-12-819641-0.00042-6 · Cited by 10
Metadata
- Authors
- Lu, H., Chan, S. S. M., Chan, W. C., Lin, C., Cheng, C. P. W., & Linda Chiu Wa, L.
- Venue
- Annals of Clinical and Translational Neurology
- Publisher
- Wiley
- Published
- 2019-09-17
- Volume
- 6
- Issue
- 10
- Pages
- 1938-1948
- ISSN
- 2328-9503 (ISSN-L)
- OpenAlex
- W2973351917
- Cited by
- 96
- References
- 12
- FWCI
- 2.31
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Randomized controlled trial of TDCS on cognition in 201 seniors with mild neurocognitive disorder. https://app.cochat.ai/papers/10.1002/acn3.50823
- The paper
- Lu, H., Chan, S. S. M., Chan, W. C., Lin, C., Cheng, C. P. W., & Linda Chiu Wa, L. (2019). Randomized controlled trial of TDCS on cognition in 201 seniors with mild neurocognitive disorder. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.50823
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.